Advertisement
Screener

INOVIO PHARMACEUTICALS, INC. (INO) Payments to Noncontrolling Interests

2.8 / 5 stars · 68/120 Roast Me

INOVIO PHARMACEUTICALS, INC. Payments to Noncontrolling Interests

INOVIO PHARMACEUTICALS, INC. (INO) reported Payments to Noncontrolling Interests of $0 for the 9-month period ending 2017-09-30, per its 10-Q filed 2017-11-08.

Discontinued › Cash Flow › Other Cash Flow Items

us-gaap:PaymentsToMinorityShareholders · last filed 2017-11-08

  • INOVIO PHARMACEUTICALS, INC. payments to noncontrolling interests for the quarter ending 2017-09-30 was $0.00.
  • INOVIO PHARMACEUTICALS, INC. payments to noncontrolling interests for the quarter ending 2016-09-30 was $0.00, a 100.00% decline year-over-year.
  • INOVIO PHARMACEUTICALS, INC. payments to noncontrolling interests for the quarter ending 2015-09-30 was $149.56K.
Period endPayments to Noncontrolling Interests 3 monthPayments to Noncontrolling Interests 6 monthPayments to Noncontrolling Interests 9 month
2017-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08
$0.00
10-Q · filed 2017-11-08
2017-06-30$0.00
10-Q · filed 2017-08-08
2016-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08
$149.56K
10-Q · filed 2017-11-08
2016-06-30$149.56K
10-Q · filed 2017-08-08
2015-09-30$149.56K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09
$149.56K
10-Q · filed 2016-11-09
2015-06-30$0.00
10-Q · filed 2016-08-08
2014-09-30$0.00
10-Q · filed 2015-11-09

Similar stocks

Stock NameCountryMarket CapPE Ratio
IMMUNIC, INC. (IMUX)United States$0.127B-1.88
Aardvark Therapeutics, Inc. (AARD)United States$0.121B-1.80
CUMBERLAND PHARMACEUTICALS INC (CPIX)United States$0.121B-8.95
Coya Therapeutics, Inc. (COYA)United States$0.121B-6.35
MEDICINOVA INC (MNOV)United States$0.130B-6.04
NRX Pharmaceuticals, Inc. (NRXP)United States$0.131B-6.31
OnKure Therapeutics, Inc. (OKUR)United States$0.119B-3.13
Unicycive Therapeutics, Inc. (UNCY)United States$0.134B-3.70
TuHURA Biosciences, Inc./NV (HURA)United States$0.134B-4.88
Immuneering Corp (IMRX)United States$0.113B-12.51